Turning the tide: pembrolizumab's triumph in adjuvant RCC therapy.
Saved in:
| Title: | Turning the tide: pembrolizumab's triumph in adjuvant RCC therapy. |
|---|---|
| Authors: | Attieh F; Faculty of Medicine, Saint Joseph University of Beirut, Riad El Solh, 11-5076, Beirut, 11072180, Lebanon. fouad.attieh@net.usj.edu.lb., Boutros M; Faculty of Medicine, Saint Joseph University of Beirut, Riad El Solh, 11-5076, Beirut, 11072180, Lebanon., Kourie HR; Department of Hematology-Oncology, Faculty of Medicine, Saint Joseph University of Beirut, Riad El Solh, 11-5076, Beirut, 11072180, Lebanon., Mahrous M; Oncology Department, Prince Sultan Military Medical City, Makkah Al Mukarramah Rd, As Sulimaniyah, Riyadh, 12233, Kingdom of Saudi Arabia.; Oncology Department, Faculty of Medicine, Minia University, Minia, Egypt. |
| Source: | Medical oncology (Northwood, London, England) [Med Oncol] 2024 Sep 05; Vol. 41 (10), pp. 242. Date of Electronic Publication: 2024 Sep 05. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
